Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Sean Bohen — FY2025 total compensation $3,178,990

Sean Bohen is President and Chief Executive Officer of Olema Pharmaceuticals, Inc. (OLMA). The company reported total compensation of $3,178,990 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$699,920
Bonus$0
Stock awards$0
Option awards$2,002,000
Non-equity incentive plan$461,900
Pension and non-qualified deferred compensation$0
All other compensation$15,170
Total$3,178,990

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Olema Pharmaceuticals, Inc. filed April 29, 2026, accession 0001193125-26-191956.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$699,920$0$0$2,002,000$461,900$0$15,170$3,178,990
FY2024President and Chief Executive Officer$673,000$0$0$7,010,520$432,066$0$14,970$8,130,556

Totals as disclosed in each year's own compensation disclosure for Olema Pharmaceuticals, Inc..

03

Peer context

Peer-group chief executive median$4,917,511
Difference from that median$-1,738,521
Percentile within the disclosed peer group27th
Peers with a disclosed figure22

Medians and percentiles are computed across the peer group Olema Pharmaceuticals, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Olema Pharmaceuticals, Inc.

Named executive officerRoleFY2025 total
Sean Bohen this pagePresident and Chief Executive Officer$3,178,990
Shawnte MitchellChief Legal Officer and Corporate Secretary$2,050,750
Shane KovacsChief Operating and Financial Officer$1,888,335

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Olema Pharmaceuticals, Inc. compensation brief.

05

The company page

Sean Bohen's compensation sits inside Olema Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Olema Pharmaceuticals, Inc. (OLMA) compensation brief